Just months after going bankrupt, genetic-testing giant 23andMe quietly auctioned off its most valuable treasure—your DNA data—to pharma heavyweight Regeneron for $256 million. Regeneron promises to respect your privacy, keep running the services that connect you with distant relatives, and let you know how caffeine affects your sleep.
Unsurprisingly, privacy advocates remain skeptical. Ultimately, trusting a pharma giant with your DNA is like trusting a lion with your gazelle.
